Allow the medication to reach room temperature if it has been refrigerated (typically 1530 minutes), as cold injections can be more uncomfortable
Protecting patients and trust The dangers are abundantly clear: a poorly regulated peptide market awash with misinformation will set back progress in obesity medication by years and put people in danger
A Phase 1a, blinded, placebo-controlled, randomized, single- and multiple-ascending-dose study was done to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of orforglipron
In the Phase 2 obesity trial published in NEJM in 2023, retatrutide at the 12 mg weekly dose produced a mean placebo-adjusted body weight reduction of 22.1 percentage points (22.1% (24.2% arm) mean absolute reduction on the retatrutide arm) at 48 weeks (Jastreboff et al., NEJM, 2023)
Final Thoughts GLP-1 medications can be powerful tools for weight loss, but they work best when combined with healthy habits that last beyond treatment
proper nutrition Reduced Appetite : Don't force eating, but ensure minimum nutrition (protein priority) Fullness : Eat slowly
